Showing results (171-180 of 186) with videos related to
Sort By:
Pageof 19
Lancet (London, England)|April 30, 2002
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studiesGillian F Black, Rosemary E Weir, Sian Floyd, et al.AIDS and Behavior|November 12, 2018
Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South AfricaJanet Seeley, Virginia Bond, Blia Yang, et al.Plos One|January 3, 2008
CD209 genetic polymorphism and tuberculosis diseaseFredrik O Vannberg, Stephen J Chapman, Chiea C Khor, et al.Lancet (London, England)|August 7, 2013
Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trialHelen Ayles, Monde Muyoyeta, Elizabeth Du Toit, et al.Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adultsGillian F Black, Rosemary E Weir, Steven D Chaguluka, et al.Journal of the International AIDS Society|February 20, 2020
Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)Susan H Eshleman, Estelle Piwowar-Manning, Ethan A Wilson, et al.The Lancet. HIV|November 4, 2022
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling studyWilliam J M Probert, Rafael Sauter, Michael Pickles, et al.Journal of the International AIDS Society|July 12, 2022
The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South AfricaJames R Hargreaves, Triantafyllos Pliakas, Graeme Hoddinott, et al.The Lancet. Global Health|March 15, 2021
Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trialRanjeeta Thomas, William J M Probert, Rafael Sauter, et al.Plos Pathogens|September 19, 2022
Genome-wide association study of leprosy in Malawi and MaliJames J Gilchrist, Kathryn Auckland, Tom Parks, et al.Pageof 19